Program

Home

Program

The final program for the workshop is currently being developed. The preliminary program is now available to the right of the screen in pdf format.

A number of renowned speakers have been invited to present at the workshop. Once they have confirmed their participation, their names and presentation titles will be added to this page. Thank you for your patience!

Confirmed Invited Speakers

  • Darrell Abernethy: Drug Side Effect that Mimic Aging


    Darrell R. Abernethy, MD, PhD, FACP , is responsible for leading the development of a pharmacological mechanism based safety program in the Office of Clinical Pharmacology to work in synergy with efforts in the Office of Surveillance and Epidemiology and other Offices and Centers at FDA. Dr. Abernethy brings more than 25 years of experience in medicine and pharmacology, including positions in academia, practice and research. Prior to joining FDA he served as Chief Science Officer at USP. ...

  • Todd Brown: Bone Loss


    Todd T. Brown, MD, PhD is Assistant Professor of Medicine in the Division of Endocrinology and Metabolism at Johns Hopkins University where he is also the primary endocrine consultant to the Johns Hopkins HIV Clinic. He is a graduate of Columbia University College of Physicians and Surgeons and the Johns Hopkins Bloomberg School of Public Health. He completed his clinical training at Georgetown University and Johns Hopkins. ...

  • Judith Currier: Vitamin D


    Judith S. Currier, MD, MSc, is Professor of Medicine, Chief, Division of Infectious Diseases and Co-Director of the Center for AIDS Research and Education Center (CARE) at the University of California Los Angeles at UCLA. She is Vice Chair of the NIH sponsored AIDS Clinical Trials Group and is currently the Principal Investigator of the UCLA AIDS Prevention and Treatment Clinical Trials Unit. The unit includes four sites in Los Angeles and is involved in community based prevention, HIV vaccine research and therapeutic clinical trials. ...

  • Steven Deeks: Immune Response to the Virus


    Steven G. Deeks, MD , is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and a faculty member in the Positive Health Program (AIDS Program) at San Francisco General Hospital. Dr. Deeks has been engaged in HIV research and clinical care since 1993.

    ...

  • Luigi Ferrucci: Physiological Pathway to Frailty


    Luigi Ferrucci, MD, PhD, is a geriatrician and an epidemiologist who conducts research on the causal pathways leading to progressive physical and cognitive decline in older persons. Dr. Ferrucci has made major contributions in the design of many epidemiological studies conducted in the U.S. and in Europe, including the European Longitudinal Study on Aging, the "ICare Dicomano Study," the AKEA study of Centenarians in Sardinia and the Women's Health and Aging Study. ...

  • Alan Landay: Immunology of Aging
    Landay, Alan


    Alan Landay, PhD , is Professor and Chairman of the Department of Immunology/Microbiology at Rush University Medical Center in Chicago. He has been involved in HIV research for over 25 years having performed some of the first immune evaluations of HIV infected haemophiliacs in 1982 while completing a postdoctoral fellowship at the University of Alabama, Birmingham. ...

  • Joseph Margolick: Clinical Epidemiology of Frailty


    Joseph Margolick, MD, PhD, is Professor of Molecular Microbiology and Immunology, Enviromental Health Sciences and Epidemiology at Johns Hopkins Bloomberg School of Public Health, Baltimore. In addition, he is Professor of Medicine at Johns Hopkins University School of Medicine, Baltimore. ...

  • Avindra Nath: Natural Course of Neurocognitive Changes in Aging


    Avindra Nath, MD is Professor in the Departments of Neurology and Neuroscience the Director of the Division of Neuroimmunology and Neurological Infections and the co-director of the Center for Neuro-AIDS research at Johns Hopkins University in Baltimore Maryland.


    ...

  • Janice Schwartz: Effect of Aging on Human Pharmacology
    Schwartz, Janice


    Janice B. Schwartz, MD , is a recognized leader in the area of cardiovascular aging, drug metabolism, and in the effects of gender on drug metabolism and responses. She graduated from Tulane Medical School, is a board-certified internist, cardiologist with significant experience in clinical pharmacology and geriatric medicine. She has been on the faculty of Stanford Medical School, Baylor College of Medicine, UCSF Schools of Medicine, Nursing, and Pharmacy, and was Professor of Medicine and Molecular Pharmacology and Chief of Clinical Pharmacology and Geriatric Medicine at Northwestern University Medical School until 2000 when she returned to the San Francisco Bay area. ...

  • Russell Tracy: Inflammation


    Russell P. Tracy, PhD, is Professor of Pathology and Biochemistry, Director of the Laboratory for Clinical Biochemistry Research (LCBR), and Director of Translational Technologies in the Center for Clinical and Translational Science at the University of Vermont/ Fletcher Allen Health Care. He has recently stepped down after a decade of service as Senior Associate Dean of Research & Academic Affairs at the University of Vermont College of Medicine. He has participated in HIV research since 2001. ...

  • Douglas Wallace: Mitochondrial Toxicity


    Douglas Wallace, PhD was till recently Director of the Center for Molecular and Mitochondrial Medicine and Genetics at the University of California, Irvine and a Donald Bren professor of Molecular Medicine and Professor of Biological Chemistry and of Ecology and Evolutionary Biology at the University of California, Irvine ...

logo_website

Important Dates

Registration Timelines (CET)
Application : 15 May - 31 Aug.
Registration : mid Aug. - 15 Sept.

Onsite
Registration

: not available

Abstract Submission
Start  : 15 May 2010 
Late breaker deadline  : 31 August 2010 

Preliminary Program